29 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/04/30/eli-lilly-lly-q1-2024-earnings-call-transcript/?source=iedfolrf0000001 Apr 30, 2024 - LLY earnings call for the period ending March 31, 2024.
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making https://www.fool.com/investing/2024/05/04/move-over-mounjaro-eli-lilly-has-another-blockbust/?source=iedfolrf0000001 May 04, 2024 - Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/?source=iedfolrf0000001 Feb 08, 2024 - Investors are still excited about obesity treatments and weight-management drugs.
Eli Lilly Just Succeeded Where Others Failed, but Does It Matter for the Stock? https://www.fool.com/investing/2024/02/10/eli-lilly-just-succeeded-where-others-failed-but-d/?source=iedfolrf0000001 Feb 10, 2024 - Potentially adding billions of dollars in revenue might move the needle for the pharmaceutical giant, but that could take years.
Eli Lilly: Overvaluation Is A Big Red Flag https://seekingalpha.com/article/4669991-eli-lilly-q4-earnings-overvaluation-big-red-flag?source=feed_all_articles Feb 13, 2024 - Eli Lilly has strong financial performance with steady revenue growth and profitability expansion. Find out why LLY stock is a Sell.
Eli Lilly partner BioAge wins $170M to study Zepbound combo https://seekingalpha.com/news/4066258-eli-lilly-partner-bioage-wins-170m-zepbound-combo-study?source=feed_sector_healthcare Feb 13, 2024 - Biotech startup BioAge Labs raises $170M for Phase 2 trials for a combination therapy involving Eli Lilly's Zepbound and other weight loss drugs. Read more here.
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353 Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
Is It Too Late to Buy Eli Lilly Stock Now? https://www.fool.com/investing/2024/03/02/is-it-too-late-to-buy-eli-lilly-stock-now/?source=iedfolrf0000001 Mar 02, 2024 - Eli Lilly stock is having a moment, but the company could easily continue soaring.
The $1T club could soon have its first non-tech members: Berkshire Hathaway & Eli Lilly https://seekingalpha.com/news/4074979-the-1t-club-could-soon-have-its-first-non-tech-members-berkshire-hathaway-eli-lilly?source=feed_sector_healthcare Mar 02, 2024 - Berkshire Hathaway (BRK.A) (BRK.B) & Eli Lilly (LLY) could become the first non-tech companies to hit $1T in market cap. Read more here.
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock. https://www.fool.com/investing/2024/03/09/missed-out-on-eli-lilly-novo-nordisk-this-could/?source=iedfolrf0000001 Mar 09, 2024 - Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.

Pages: 123

<Page 2